Flunixin Meglumine
C14H11F3N2O2·C7H17NO5
491.46
3-Pyridinecarboxylic acid, 2-[[2-methyl-3-(trifluoromethyl)phenyl]amino]-, compd. with 1-deoxy-1-(methylamino)-d-glucitol (1:1);
2-(α3,α3,α3-Trifluoro-2,3-xylidino)nicotinic acid compound with 1-deoxy-1-(methylamino)-d-glucitol (1:1)
1-Deoxy-1-(methylamino)-d-glucitol 2-{[2-methyl-3-(trifluoromethyl)phenyl]amino}nicotinate [42461-84-7]
491.46
3-Pyridinecarboxylic acid, 2-[[2-methyl-3-(trifluoromethyl)phenyl]amino]-, compd. with 1-deoxy-1-(methylamino)-d-glucitol (1:1);
2-(α3,α3,α3-Trifluoro-2,3-xylidino)nicotinic acid compound with 1-deoxy-1-(methylamino)-d-glucitol (1:1)
1-Deoxy-1-(methylamino)-d-glucitol 2-{[2-methyl-3-(trifluoromethyl)phenyl]amino}nicotinate [42461-84-7]
DEFINITION
Flunixin Meglumine contains NLT 98.0% and NMT 102.0% of flunixin meglumine (C14H11F3N2O2·C7H17NO5).
USP REFERENCE STANDARDS FOR PURCHASE
USP Flunixin Meglumine RSUSP Flunixin Related Compound A RS
USP Flunixin Related Compound B RS
USP Flunixin Related Compound C RS